Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3703, Durham, NC 27710
Phone (919) 681-6386
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine/Nephrology, Vice Chair for Faculty Development and Diversity in the Department of Medicine, and School of Medicine Faculty Ombudsperson. She is also the Director of Duke’s CTSA-sponsored internal career development award program (KL2) and the Investigator Development Core of Duke’s REACH Equity Disparities Research Center.

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is an American Society of Hypertension certified hypertension specialist, and a member of the Association of American Physicians (AAP). She is the Associate Director, Core Director and Project PI of Duke’s REACH Equity Disparities Research Center.

As Department of Medicine Vice Chair for Faculty Development and Diversity, she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

As School of Medicine Faculty Ombudsperson, she helps faculty resolve concerns by providing confidential, impartial, informal guidance.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Debatin, J. F., C. E. Spritzer, T. M. Grist, C. Beam, L. P. Svetkey, G. E. Newman, and H. D. Sostman. “Imaging of the renal arteries: value of MR angiography.” Ajr Am J Roentgenol 157, no. 5 (November 1991): 981–90. https://doi.org/10.2214/ajr.157.5.1927823.

PMID
1927823
Full Text

Svetkey, L. P., S. Kadir, N. R. Dunnick, S. R. Smith, C. B. Dunham, M. Lambert, and P. E. Klotman. “Similar prevalence of renovascular hypertension in selected blacks and whites.” Hypertension 17, no. 5 (May 1991): 678–83. https://doi.org/10.1161/01.hyp.17.5.678.

PMID
2022411
Full Text

Roubidoux, M. A., N. R. Dunnick, P. E. Klotman, G. E. Newman, R. H. Cohan, S. Kadir, and L. P. Svetkey. “Renal vein renins: inability to predict response to revascularization in patients with hypertension.” Radiology 178, no. 3 (March 1991): 819–22. https://doi.org/10.1148/radiology.178.3.1994424.

PMID
1994424
Full Text

Black, H. R., J. J. Bourgoignie, T. Pickering, L. Svetkey, M. C. Saddler, J. F. Setaro, and S. C. Textor. “Report on the working party group for patient selection and preparation.” American Journal of Hypertension 4, no. 12 II SUPPL. (1991): 745S-746S.

Scholars@Duke

Weir, M. R., N. D. Vlachkis, V. DeQuattro, J. Douglas, L. P. Svetkey, S. Singh, S. C. Wiedl, C. F. Chen, D. L. Woodward, and E. Saunders. “Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension.” J Clin Pharmacol 30, no. 5 (May 1990): 425–37. https://doi.org/10.1002/j.1552-4604.1990.tb03481.x.

PMID
2189903
Full Text

SVETKEY, L. P., C. B. DUNHAM, and P. E. KLOTMAN. “ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR VERSUS CONVENTIONAL THERAPY IN THE TREATMENT OF HYPERTENSION IN PATIENTS WITH RENAL-INSUFFICIENCY.” Clinical Research 38, no. 2 (April 1, 1990): A576–A576.

Scholars@Duke

SMITH, S. R., P. E. KLOTMAN, and L. P. SVETKEY. “ACUTE EFFECT OF ORAL POTASSIUM ON BLOOD-PRESSURE AND RENAL-FUNCTION IN MILD HYPERTENSION.” Clinical Research 38, no. 1 (January 1, 1990): A22–A22.

Scholars@Duke

Svetkey, L. P., S. I. Himmelstein, N. R. Dunnick, R. H. Wilkinson, R. R. Bollinger, R. L. McCann, E. M. Beytas, and P. E. Klotman. “Prospective analysis of strategies for diagnosing renovascular hypertension.” Hypertension 14, no. 3 (September 1989): 247–57. https://doi.org/10.1161/01.hyp.14.3.247.

PMID
2670763
Full Text

SVETKEY, L. P., and P. E. KLOTMAN. “CAPTOPRIL-STIMULATED PLASMA-RENIN AND THE CAPTOPRIL TEST AS SCREENING-TESTS FOR RENOVASCULAR HYPERTENSION.” Clinical Research 37, no. 2 (April 1, 1989): A401–A401.

Scholars@Duke

Pages